VREX · Varex Imaging Corp · Metrics
$18.49
+0.03 (+0.16%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$776.75M
Shares
42.10M
Volume · Oct 5
95.2K
Avg daily vol (3M)
830.67K
VREX metrics
81 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$18.46
Market cap
$776.75M
Price action
20 metricsPrice change (1W)
+0.1%
Price change (30D)
-0.3%
Price change (3M)
+74.0%
Price change (6M)
+75.8%
Price change (YTD)
+58.5%
Price change (1Y)
+55.6%
Trailing year
Price change (5Y)
-35.4%
52-week high
$18.58
52-week low
$9.32
Change from 52-week high
-0.6%
Change from 52-week low
+98.1%
Annualized volatility
63.8%
Annualized volatility (3M)
98.2%
Beta
1.2
RSI (14D)
75.7
Price vs SMA 50
+8.8%
Price vs SMA 200
+42.0%
Avg volume (3M)
830,673
Relative volume
0.5
Average dollar volume
$14.34M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
42.10M
Valuation
12 metricsP / E (TTM)
35.5
Trailing earnings · reciprocal yield 2.8%
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 84.4%
EV / EBITDA
—
EV / EBIT
14.2×
reciprocal yield 7.0%
P / sales
0.9×
reciprocal yield 111.4%
P / book
1.6
reciprocal yield 63.9%
FCF yield
-2.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
68.7
reciprocal yield 1.5%
Earnings yield
2.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
36.7×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
1.0×
reciprocal yield 99.0%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 84.7%
EV / EBIT historical average (3Y)
17.7×
reciprocal yield 5.6%
EV / EBIT historical average (5Y)
16.3×
reciprocal yield 6.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-10
Profitability
9 metricsGross margin
34.3%
Operating margin
8.3%
Trailing 12 months
Net margin
2.6%
Gross profit (TTM)
$296.90M
Operating profit (TTM)
$72.20M
Net income (TTM)
$22.10M
Trailing 12 months
Diluted EPS (TTM)
$0.52
FCF margin
-2.3%
Effective tax rate
18.8%
Growth
11 metricsRevenue growth YoY
+3.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$865.00M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
-0.6%
Revenue CAGR (5Y)
+2.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
4.5%
Return on assets
2.0%
Debt / equity
0.7
Current ratio
3.4
EBITDA (TTM)
—
Free cash flow (TTM)
−$20.20M
Quick ratio
1.5
Interest coverage
1.9
Net debt / EBITDA
—
Return on invested capital
7.9%
Trailing 12 months
Net cash
−$247.90M
Latest balance sheet
Cash & equivalents
$99.20M
Total assets
$1.10B
Total debt
$347.10M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$11.30M
Capital expenditures (TTM)
$31.50M
R&D (TTM)
$91.40M
SG&A (TTM)
$133.30M
Stock compensation (TTM)
$15.00M
R&D / revenue
10.6%
Stock compensation / revenue
1.7%
Ownership (13F)
3 metrics13F filers
186
13F filer change QoQ
+8
Institutional ownership
95.5%
Short interest
3 metricsShort interest
3.3%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
51 / 100
Insider activity
2 metricsNet insider buying (90D)
−$2.55M
Insider-sentiment score
19 / 100
Risk flags
1 metricsGoing concern
—